Molterfin 2 mg Resoriblett, sublingual

País: Suecia

Idioma: sueco

Fuente: Läkemedelsverket (Medical Products Agency)

Ingredientes activos:

buprenorfinhydroklorid

Disponible desde:

L Molteni & C Dei F.LLI Alitti Societa di Esercizio SpA

Código ATC:

N07BC01

Designación común internacional (DCI):

buprenorphine hydrochloride

Dosis:

2 mg

formulario farmacéutico:

Resoriblett, sublingual

Composición:

mannitol Hjälpämne; laktosmonohydrat Hjälpämne; buprenorfinhydroklorid 2,16 mg Aktiv substans

clase:

Apotek

tipo de receta:

Receptbelagt

Área terapéutica:

Buprenorfin

Resumen del producto:

Förpacknings: Strip, 7 tabletter; Strip, 14 tabletter; Strip, 28 tabletter; Strip, 140 (5 x 28) tabletter

Estado de Autorización:

Godkänd

Fecha de autorización:

2010-07-02

Información para el usuario

1
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
MOLTERFIN 2 MG SUBLINGUAL TABLETS
MOLTERFIN 8 MG SUBLINGUAL TABLETS
buprenorphine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even
if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Molterfin is and what it is used for
2.
What you need to know before before you take Molterfin
3.
How to take Molterfin
4.
Possible side effects
5.
How to store Molterfin
6.
Contents of the pack and other information.
1.
WHAT MOLTERFIN IS AND WHAT IT IS USED FOR
Molterfin contains the active substance buprenorphine.
Molterfin is used:

if you are addicted to opioids, e. g. heroin or morphine, within a
framework of medical, social and
psychological treatment.
The treatment is prescribed and monitored by doctors specialized in
treating drug addiction.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE MOLTERFIN
DO NOT TAKE
MOLTERFIN IF YOU:

are allergic to buprenorphine or any of the other ingredients of this
medicine (listed in section 6).

suffer from serious breathing difficulties

suffer from a seriously reduced liver function

suffer from alcoholism or delirium tremens.
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking
Molterfin if you:

have taken morphine or heroin (opioids) less than 6 hours ago, as
withdrawal symptoms can occur

have taken methadone less than 24 hours ago, as withdrawal symptoms
can occur (if you use
methadone your dose may have to be adjusted before you take
buprenorphine, see section 3)

suffer from asthma or breathing difficulties
2

suffer from reduced

Ficha técnica

MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_